296
ARFAN et al.
0.75. IR spectrum, ν, cm–1: 1600 (C=O), 1582 (C=N),
1570 (C=C), 1308 [C(CH3)3], 1300 (C–O), 712 (C–S).
Mass spectrum, m/z: 264 [M]+, 208 [MacLafferty], 164
[MacLafferty 1], 148 [C8H6NS], 134 [C7H4NS], 108
[C6H4S].
2. Gaba, M., Singh, D., Singh, S., Sharma, V., and
Gaba, P., Eur. J. Med. Chem., 2010, vol. 45, p. 2245.
3. Paramashivappa, R., Kumar, P.P., Rao, P.V.S., and
Rao, A.S., Bioorg. Med. Chem. Lett., 2003, vol. 13,
p. 657.
4. Batista, R.M.F., Costa, S.P.G., and Raposo, M.M.M.,
Tetrahedron Lett., 2004, vol. 45, p. 2825.
5. Evindar, G. and Batey, R.A., J. Org. Chem.,
2006, vol. 71, p. 1802.
tert-Butyl [1-(1,3-benzothiazol-2-yl)-3-methylbu-
tyl]carbamate (4b) was prepared by the general
procedure using amino acid 2b. Yield 96%, mp 89–
91°C, Rf 0.84. IR spectrum, ν, cm–1: 1735 (C=O),
1605 (C=N), 1600 (C=C), 1298 [C(CH3)3], 1300 (C–
O), 710 (C–S). Mass spectrum, m/z: 320 [M]+, 277
[M – CH(CH3)2]+, 263 [M – CH2CH(CH3)2]. Second
Route: 264 [MacLafferty], 220 [MacLafferty 1], 204
[C12H15NS], 134 [C7H4NS].
6. Ma, D., Xie, S., Xue, P., Zhang, X., Dong, J., and
Kiang, Y., Angew. Chem., Int. Ed., 2009, vol. 48,
p. 4222.
tert-Butyl
2-(1,3-benzothiazol-2-ylmethyl)pyr-
rolidine-1-carboxylate (4c). Yield 98%, mp 95–99°C,
Rf 0.81. IR spectrum, ν, cm–1: 1717 (C=O), 1600 (C=C),
1614 (C=N), 1280 [C(CH3)3], 1100 (C–O), 710 (C–S).
Mass spectrum, m/z: 304 [M]+, 248 [MacLafferty], 204
[C11H12N2S], 190 [C10H10N2S], 134 [C7H4NS].
7. Jaseer, E.A., Prasad, D.J.C., Dandapat, A., and Sekar, G.,
Tetrahedron Lett., 2010, vol. 51, p. 5009.
8. Ma, D., Lu, X., Shi, L., and Zhang, H., Angew.
Chem., Int. Ed., 2011, vol. 50, p. 1118.
9. Deng, H., Li, Z., Ke, F., and Zhou, X., Chem.
Eur. J., 2012, vol. 18, p. 4840.
tert-Butyl
[1-(1,3-benzothiazol-2-yl)-2-(4-hyd-
roxyphenyl)ethyl]carbamate (4d). Yield 92%, mp
135–137°C, Rf 0.76. IR spectrum, ν, cm–1: 1680 (C=O),
1603 (C=N), 1582 (C=C), 1305 (C–O), 714 (C–S).
Mass spectrum, m/z: 393 [M]+, 263 [M – C8H6N]+, 337
[MacLafferty 1], 293 [MacLafferty], 134 [C7H4NS].
10. Inamoto, K., Hasegawa, C., Hiroya, K., and Doi, T.,
Org. Lett., 2008, vol. 10, p. 5147.
11. Bochatay, V.N., Boissarie, P.J., Murphy, J.A., Suckling, C.J.,
and Lang, S., J. Org. Chem., 2013, vol. 78, p. 1471.
12. Bose, D.S. and Idrees, M., J. Org. Chem., 2006,
vol. 71, p. 8261.
13. Gupta, S.D., Singh, H.P., and Moorthy, N., Synth.
Commun., 2007, vol. 37, p. 4327.
14. Siddappa, C., Kambappa, V., Umashankara, M., and
Rangappa, K.S., Tetrahedron Lett., 2011, vol. 52, p. 5474.
15. Zhao, J., Huang, H., Wu, W., Chen, H., and Jiang, H.,
Org. Lett., 2013, vol. 15, p. 2604.
tert-Butyl
[1-(1,3-benzothiazol-2-yl)-2-methyl-
propyl]carbamate (4e). Yield 54%, mp 138–140°C, Rf
0.70. IR spectrum, ν, cm–1: 1735 (C=O), 1604 (C=N),
1578 (C=C), 1299 [C(CH3)3], 1241 (C–O), 700 (C–S).
Mass spectrum, m/z: 306 [M]+, 250 [MacLafferty 1], 206
[MacLafferty], 190 [C9H6NS(CH3)3], 134 [C7H4NS],
108 [C6H4S].
tert-Butyl
[1-(1,3-benzothiazol-2-yl)-2-phenyl-
ethyl]carbamate (4f). Yield 90%, mp 80–84°C, Rf
0.65. IR spectrum, ν, cm–1: 1693 (C=O), 1607 (C=N),
1506 (C=C), 1366 [C(CH3)3], 1156 (C–O), 715 (C–S).
Mass spectrum, m/z: 354 [M]+, 298 (MacLafferty), 238
[C7H4NSC8H8], 134 [C7H4NS], 254 [MacLafferty 2],
207 [M – C(CH3)3CH2C6H5]+.
CONFLICT OF INTEREST
The authors declare no conflict of interest.
REFERENCES
16. Li, Y., Wang, Y.-L., and Wang, J.-Y., Chem. Lett.,
2006, vol. 35, p. 460.
17. Deshidi, R., Devari, S., and Shah, B.A., Eur. J. Org.
Chem., 2015, p. 1428.
1. Saeed, S., Rashid, N., Jones, P.G., Ali, M., and
Hussain, R., Eur. J. Med. Chem., 2010, vol. 45, p. 1323.
RUSSIAN JOURNAL OF ORGANIC CHEMISTRY Vol. 56 No. 2 2020